Management of Hyperglycemia in Gestational Diabetes Mellitus

Authors: Akinci, Baris; Yener, Serkan; Celtik, Aygul; Sevindik, Gokmen; Yesil, Sena

Source: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, Volume 2, Number 2, June 2008 , pp. 123-128(6)

Publisher: Bentham Science Publishers

Buy & download fulltext article:

Price: $104.88 plus tax (Refund Policy)

Abstract:

Gestational diabetes mellitus is a common disorder which is defined as any degree of glucose intolerance with onset at, or first recognized during pregnancy. Women with gestational diabetes are at greater risk for many adverse pregnancy outcomes and maternal or fetal mortality. We tried to conduct the cumulative experience regarding the management of the disease, especially emphasizing the novel therapeutic approaches like new types of insulin preparations, oral hypoglycemic agents and herbal drugs or supplements. In this review important recent patents are also discussed.

Keywords: Diabetes; pregnancy; insulin; oral antidiabetics; medical nutrition; exercise

Document Type: Research article

DOI: http://dx.doi.org/10.2174/187221408784534286

Publication date: 2008-06-01

More about this publication?

Recent Patents on Endocrine, Metabolic & Immune Drug Discovery publishes review articles by experts on recent patents in the field of endocrine, metabolic and immune drug discovery e.g. on novel bioactive compounds, analogs & targets. A selection of important and recent patents in the field is also included in the journal. The journal is essential reading for all researchers involved in endocrine, metabolic and immune drug design and discovery.